Patents by Inventor Ritesh Sanghvi

Ritesh Sanghvi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delayed Release Compositions of Linaclotide
    Publication number: 20230398173
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 14, 2023
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • Delayed Release Compositions of Linaclotide
    Publication number: 20230142270
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: December 30, 2022
    Publication date: May 11, 2023
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • LINACLOTIDE COMPOSITIONS
    Publication number: 20200222541
    Abstract: The present invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions.
    Type: Application
    Filed: January 11, 2019
    Publication date: July 16, 2020
    Inventors: Ritesh Sanghvi, Matthew Miller, Andreas Grill, Yun Mo, Mohammad Mafruhul Bari, Matthew Ronsheim, Joseph Stainkamp
  • Micronized colistimethane sodium pharmaceutical compositions
    Patent number: 10441536
    Abstract: Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometers but not less than 3 micrometers and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: October 15, 2019
    Assignee: ACTAVIS GROUP PTC EHF
    Inventors: Richard Anthony Flynn, Rahul Surana, Anil Chhettry, David Farrington, Ritesh Sanghvi
  • Crystalline And Amorphous Forms Of A Beta-Arrestin Effector
    Publication number: 20170283464
    Abstract: The present disclosure provides novel crystalline forms of a compound that acts as a ?-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a ?-arrestin effector and uses thereof.
    Type: Application
    Filed: November 7, 2016
    Publication date: October 5, 2017
    Inventors: Ritesh Sanghvi, Gregory Alcorn, Graham Richard Lawton, Meiki Yu, Matthew Ronsheim, Jiaher Tian, Shao Hong Zhou, Yuriy B. Kalyan
  • LINACLOTIDE COMPOSITIONS
    Publication number: 20170281774
    Abstract: The present invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions.
    Type: Application
    Filed: March 17, 2017
    Publication date: October 5, 2017
    Inventors: Ritesh Sanghvi, Matthew Miller, Andreas Grill, Yun Mo, Mohammad Mafruhul Bari, Matthew Ronsheim, Joseph Stainkamp
  • Crystalline and amorphous forms of a ?-arrestin effector
    Patent number: 9518086
    Abstract: The present disclosure provides novel crystalline forms of a compound that acts as a ?-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a ?-arrestin effector and uses thereof.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: December 13, 2016
    Assignee: Trevena, Inc.
    Inventors: Ritesh Sanghvi, Gregory Alcorn, Graham Richard Lawton, Meiki Yu, Matthew Ronsheim, Jiaher Tian, Shao Hong Zhou, Yuriy B. Kalyan
  • LINACLOTIDE COMPOSITIONS
    Publication number: 20160324968
    Abstract: The present invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions.
    Type: Application
    Filed: March 11, 2016
    Publication date: November 10, 2016
    Inventors: Ritesh Sanghvi, Matthew Miller, Andreas Grill, Yun Mo, Mohammad Mafruhul Bari, Matthew Ronsheim, Joseph Stainkamp
  • Delayed Release Compositions of Linaclotide
    Publication number: 20160310559
    Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
    Type: Application
    Filed: December 11, 2014
    Publication date: October 27, 2016
    Inventors: Angelika Fretzen, Mark G. Currie, Ahmad Hashash, Mahendra Dedhiya, Yun Mo, Anil Chhettry, Matthew Miller, Ritesh Sanghvi, Mohammad Mafruhul Bari, Andreas Grill
  • Linaclotide compositions
    Patent number: 9283261
    Abstract: The present invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: March 15, 2016
    Assignee: Forest Laboratories Holdings Limited
    Inventors: Ritesh Sanghvi, Matthew Miller, Andreas Grill, Yun Mo, Mohammad Mafruhul Bari, Matthew Ronsheim, Joseph Stainkamp
  • MICRONIZED PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160022577
    Abstract: Described herein are micronized powder particles of colistimethate sodium wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometres but not less than 3 micrometres and the powder has a total moisture content of from 5 to 10% by weight, for use in the treatment of a pulmonary infection by powder inhalation, wherein the colistimethate sodium is not separated into component form. The micronized powder particles of colistimethate sodium are useful in the treatment of infections caused by gram-negative bacteria, particularly in patients suffering from cystic fibrosis.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 28, 2016
    Inventors: Richard Anthony Flynn, Rahul Surana, Anil Chhettry, David Farrington, Ritesh Sanghvi
  • CRYSTALLINE AND AMORPHOUS FORMS OF A BETA-ARRESTIN EFFECTOR
    Publication number: 20150225461
    Abstract: The present disclosure provides novel crystalline forms of a compound that acts as a ?-arrestin effector, processes for preparing novel crystalline and amorphous forms of a compound that acts as a ?-arrestin effector and uses thereof
    Type: Application
    Filed: February 6, 2015
    Publication date: August 13, 2015
    Inventors: Ritesh Sanghvi, Gregory Alcorn, Graham Richard Lawton, Meiki Yu, Matthew Ronsheim, Jiaher Tian, Shao Hong Zhou, Yuriy B. Kalyan
  • LINACLOTIDE COMPOSITIONS
    Publication number: 20150005241
    Abstract: The present invention is directed to stable linaclotide compositions and methods of treating gastrointestinal disorders in patients in need thereof by providing the stable linaclotide compositions.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Ritesh Sanghvi, Matthew Miller, Andreas Grill, Yun Mo, Mohammad Mafruhul Bari, Matthew Ronsheim, Joseph Stainkamp
  • CRYSTALLINE FORM OF LINACLOTIDE
    Publication number: 20120309695
    Abstract: The present invention relates to crystalline forms of linaclotide, as well as to various methods and processes for the preparation and use of the crystalline forms.
    Type: Application
    Filed: August 15, 2012
    Publication date: December 6, 2012
    Applicant: FOREST LABORATORIES HOLDINGS LTD.
    Inventors: Ritesh Sanghvi, Andreas Grill, Rahul Surana, Hiajian Zhu
  • Crystalline form of linaclotide
    Patent number: 8293704
    Abstract: The present invention relates to crystalline forms of linaclotide, as well as to various methods and processes for the preparation and use of the crystalline forms.
    Type: Grant
    Filed: April 27, 2012
    Date of Patent: October 23, 2012
    Inventors: Ritesh Sanghvi, Andreas Grill, Rahul Surana, Hiajian (Jim) Zhu
  • CRYSTALLINE FORM OF LINACLOTIDE
    Publication number: 20120214750
    Abstract: The present invention relates to crystalline forms of linaclotide, as well as to various methods and processes for the preparation and use of the crystalline forms.
    Type: Application
    Filed: April 27, 2012
    Publication date: August 23, 2012
    Applicant: FOREST LABORATORIES HOLDINGS LTD.
    Inventors: Ritesh Sanghvi, Andreas Grill, Rahul Surana, Haijian Zhu
  • Crystalline form of linaclotide
    Patent number: 8222201
    Abstract: The present invention relates to crystalline forms of linaclotide, as well as to various methods and processes for the preparation and use of the crystalline forms.
    Type: Grant
    Filed: November 18, 2009
    Date of Patent: July 17, 2012
    Inventors: Ritesh Sanghvi, Andreas Grill, Rahul Surana, Haijian Zhu
  • CRYSTALLINE FORM OF LINACLOTIDE
    Publication number: 20100125056
    Abstract: The present invention relates to crystalline forms of linaclotide, as well as to various methods and processes for the preparation and use of the crystalline forms.
    Type: Application
    Filed: November 18, 2009
    Publication date: May 20, 2010
    Inventors: Ritesh Sanghvi, Andreas Grill, Rahul Surana, Haijian Zhu